• Health & Medicine

Cancer blood test uses 'noise cancellation' to improve sensitivity

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods. Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

18 June 2020

• Health & Medicine

Immunotherapy treatment recommended for advanced small cell lung cancer 

A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer. A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.

5 June 2020

• Science & Technology

Moves and countermoves: How the immune system responds to lung cancer’s ‘tactics’

Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time Scientists working on the TRACERx project have mapped how the immune systems responds to lung tumours over time

4 June 2020

• For Supporters

The power of philanthropy: TRACERx

In the first of a new blog series on the power of philanthropy, we look at TRACERx – the first longitudinal, large-scale study of lung cancer evolution. In the first of a new blog series on the power of philanthropy, we look at TRACERx – the first longitudinal, large-scale study of lung cancer evolution.

4 June 2020

• Health & Medicine

Over 2 million people in backlog for cancer care

Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK. Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK.

1 June 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• Science & Technology

Pancreatic cancer cells use the same energy as sprinters’ muscles to spread

Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread. Our scientists are using hydrogels to understand more about how pancreatic cancer cells spread.

26 March 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Non-Hodgkin lymphoma treatment gets an initial ‘no’ for NHS use in England

A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.  A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England. 

11 March 2020

• Science & Technology

Evolution, sex and TRACERx: how cancer’s ‘spare tyre’ helps it survive  

New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer's 'spare tyre'. New research reveals how some cancer cells double their genome to help them survive. Find out more about cancer's 'spare tyre'.

5 March 2020

• Health & Medicine

‘Chemotherapy-free’ treatment for lymphoma made available for NHS use in England

New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England. New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.

28 February 2020